The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease
- 16 January 2025
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 21 (5) , 301-313
Abstract
Fracture is an under-recognized but common complication of diabetes mellitus, with an incidence approaching twofold in type 2 diabetes mellitus (T2DM) and up to sevenfold in type 1 diabetes mellitus (T1DM) compared with that in the general population. Both T1DM and T2DM induce chronic hyperglycaemia, leading to the accumulation of advanced glycosylation end products that affect osteoblast function, increased collagen crosslinking and a senescence phenotype promoting inflammation. Together with an increased incidence of microvascular disease and an increased risk of vitamin D deficiency, these factors reduce bone quality, thereby increasing bone fragility. In T1DM, reduced anabolic stimuli as well as the presence of autoimmune conditions might also contribute to reduced bone mass and increased fragility. Diabetes mellitus is the most common cause of kidney failure, and fracture risk is exacerbated when chronic kidney disease (CKD)-related mineral and bone disorders are superimposed on diabetic changes. Microvascular pathology, cortical thinning and trabecular deterioration are particularly prominent in patients with T1DM and CKD, who suffer more fragility fractures than do other patients with CKD. This Review explores the pathophysiology of bone fragility in patients with diabetes mellitus and CKD and discusses techniques to predict fracture and pharmacotherapy that might reduce fracture risk.Keywords
This publication has 165 references indexed in Scilit:
- Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsJAMA, 2024
- Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta‐analysisDiabetes/Metabolism Research and Reviews, 2019
- Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trialsDiabetes/Metabolism Research and Reviews, 2019
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With OsteoporosisJAMA, 2016
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 DiabetesJournal of Bone and Mineral Research, 2013
- Rapid cortical bone loss in patients with chronic kidney diseaseJournal of Bone and Mineral Research, 2013
- Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fracturesJournal of Bone and Mineral Research, 2012
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 DiabetesJAMA, 2011
- Calcification of the Epididymis and the Tunica Albuginea of the Corpora Cavernosa in Patients on Maintenance HemodialysisJournal of Andrology, 2004